HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osamu Sekine Selected Research

Volatile Fatty Acids

1/2018Improved glucose metabolism by Eragrostis tef potentially through beige adipocyte formation and attenuating adipose tissue inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Osamu Sekine Research Topics

Disease

5Insulin Resistance
06/2022 - 10/2009
3Hypoglycemia (Reactive Hypoglycemia)
10/2023 - 01/2015
3Diabetes Mellitus
10/2023 - 09/2019
3Type 2 Diabetes Mellitus (MODY)
01/2021 - 07/2019
3Inflammation (Inflammations)
01/2018 - 01/2012
3Atherosclerosis
09/2015 - 08/2009
2Hypertriglyceridemia
09/2019 - 06/2017
2Body Weight (Weight, Body)
01/2018 - 06/2014
2Diabetic Retinopathy (Retinopathy, Diabetic)
03/2016 - 03/2016
1Glucose Intolerance
06/2022
1Pruritus (Itching)
01/2021
1Obesity
09/2019
1Heartburn (Pyrosis)
09/2019
1Overweight
07/2019
1Hypertension (High Blood Pressure)
07/2018
1Sclerosis
09/2017
1Proteinuria
09/2017
1Hypersensitivity (Allergy)
12/2016
1Coronary Disease (Coronary Heart Disease)
12/2016
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2016
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
12/2016
1Hypesthesia (Numbness)
03/2016
1Paresthesia (Dysesthesia)
03/2016
1Hyperemia
07/2014
1Periodontal Diseases (Periodontal Disease)
06/2014
1Abdominal Obesity
04/2014
1Hyperinsulinism (Hyperinsulinemia)
07/2013
1Hyperglycemia
12/2010
1Hepatocellular Carcinoma (Hepatoma)
01/2007
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2007
1Genetic Predisposition to Disease (Genetic Predisposition)
07/2004
1Adenoma (Adenomas)
03/2004
1Neoplasms (Cancer)
03/2004
1Hyperparathyroidism
03/2004

Drug/Important Bio-Agent (IBA)

7Glucose (Dextrose)FDA LinkGeneric
10/2023 - 12/2010
6Insulin (Novolin)FDA Link
06/2022 - 07/2013
5Triglycerides (Triacylglycerol)IBA
10/2023 - 10/2009
4Hemoglobins (Hemoglobin)IBA
07/2019 - 03/2016
3Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
09/2015 - 01/2013
3FructoseIBA
07/2013 - 07/2004
2Blood Glucose (Blood Sugar)IBA
10/2023 - 01/2015
2Hormones (Hormone)IBA
06/2022 - 03/2004
2ipragliflozinIBA
01/2021 - 07/2019
2Metformin (Glucophage)FDA LinkGeneric
09/2019 - 06/2017
1CarbohydratesIBA
10/2023
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2021
1SodiumIBA
01/2021
1DiureticsIBA
01/2021
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
07/2019
1Sodium-Glucose Transport ProteinsIBA
07/2019
1Volatile Fatty AcidsIBA
01/2018
1Acetates (Acetic Acid Esters)FDA Link
01/2018
1NPHS2 proteinIBA
09/2017
1ZincIBA
12/2016
1HDL CholesterolIBA
12/2016
1MetalsIBA
12/2016
1Eicosapentaenoic AcidIBA
09/2015
1Monocyte Chemoattractant ProteinsIBA
09/2015
1Docosahexaenoic AcidsIBA
09/2015
1A-factor (Streptomyces)IBA
01/2015
1Fatty Acids (Saturated Fatty Acids)IBA
07/2014
1C-Reactive ProteinIBA
06/2014
1RNA (Ribonucleic Acid)IBA
04/2014
1Ezetimibe (Zetia)FDA Link
07/2013
1Pyruvic Acid (Pyruvate)IBA
07/2013
1Apolipoprotein B-48IBA
07/2013
13-methyladenineIBA
01/2012
1hexosaminidase CIBA
12/2010
1O-GlcNAc transferaseIBA
12/2010
1HexosaminesIBA
12/2010
1Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA
10/2009
1Toll-Like Receptor 4IBA
08/2009
1Sterol Regulatory Element Binding Protein 1IBA
01/2007
1Radioisotopes (Radionuclides)IBA
03/2004

Therapy/Procedure

4Glycemic Control
07/2019 - 01/2015
2Gastrectomy
10/2023 - 09/2019
2Therapeutics
12/2016 - 01/2015
1Fat-Restricted Diet (Diet, Fat Restricted)
06/2014